GAIN Capital (NYSE:GCAP) General Counsel Diego Rotsztain sold 3,184 shares of the company’s stock in a transaction on Monday, May 7th. The shares were sold at an average price of $8.23, for a total value of $26,204.32. Following the completion of the transaction, the general counsel now directly owns 98,663 shares in the company, valued at approximately $811,996.49. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Diego Rotsztain also recently made the following trade(s):
Get GAIN Capital alerts:
On Friday, March 16th, Diego Rotsztain sold 3,648 shares of GAIN Capital stock. The shares were sold at an average price of $7.19, for a total value of $26,229.12. On Tuesday, March 6th, Diego Rotsztain sold 2,120 shares of GAIN Capital stock. The shares were sold at an average price of $7.41, for a total value of $15,709.20.
Shares of GCAP stock traded up $0.12 during mid-day trading on Friday, hitting $8.18. The stock had a trading volume of 2,500 shares, compared to its average volume of 473,150. GAIN Capital has a 12-month low of $8.09 and a 12-month high of $8.18. The stock has a market capitalization of $364.30 million, a price-to-earnings ratio of 14.54, a P/E/G ratio of 1.43 and a beta of 0.01. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.46.
Top 5 Heal Care Stocks To Watch For 2019: PHH Corp(PHH)
- [By Logan Wallace]
PHH (NYSE: PHH) and Orix (NYSE:IX) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.
- [By Stephan Byrd]
Media headlines about PHH (NYSE:PHH) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. PHH earned a news impact score of 0.17 on Accern’s scale. Accern also gave news coverage about the credit services provider an impact score of 45.9794154743809 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
- [By Max Byerly]
Orix (NYSE: IX) and PHH (NYSE:PHH) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.
- [By Max Byerly]
PHH (NYSE:PHH) is scheduled to be announcing its earnings results after the market closes on Tuesday, May 8th. Analysts expect the company to announce earnings of ($0.94) per share for the quarter.
- [By Ethan Ryder]
New York State Common Retirement Fund decreased its stake in shares of PHH Co. (NYSE:PHH) by 25.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,300 shares of the credit services provider’s stock after selling 9,800 shares during the quarter. New York State Common Retirement Fund’s holdings in PHH were worth $306,000 as of its most recent SEC filing.
Top 5 Heal Care Stocks To Watch For 2019: Madrigal Pharmaceuticals, Inc. (MDGL)
- [By Lisa Levin] Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
- [By George Budwell]
Shares of the clinical-stage biotechViking Therapeutics (NASDAQ:VKTX) are soaring this morning following positive mid-stage trial results for Madrigal Pharmaceuticals’ (NASDAQ:MDGL) nonalcoholicsteatohepatitis (NASH) candidateMGL-3196.
- [By Keith Speights]
Madrigal Pharmaceuticals (NASDAQ:MDGL), Viking Therapeutics (NASDAQ:VKTX), and Lexicon Pharmaceuticals (NASDAQ:LXRX) stocks ranked as especially big winners over the last few days. What lit a fire beneath these stocks — and are they smart picks to buy now? Here’s what you need to know.
Top 5 Heal Care Stocks To Watch For 2019: Calavo Growers, Inc.(CVGW)
- [By Peter Graham]
Small cap avocado and fresh food stock Calavo Growers (NASDAQ: CVGW) has elevated short interest of 33.51% according to Highshortinterest.com. Founded in 1924, Calavo Growers is a global avocado-industry leader and an expanding provider of value-added fresh food serving retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers worldwide. The Companys Fresh segment procures and markets fresh avocados and select other fresh produce (tomatoes) while the Renaissance Food Group segment (RFG) creates, markets and distributes a portfolio of healthy, fresh foods, including fresh-cut fruit, fresh-cut vegetables and prepared foods. The Foods segment manufactures and distributes guacamole and salsa. Fresh food products are sold under the respected Calavo brand name as well as Garden Highway, Chef Essentials and a variety of private label and store brands.
- [By Asit Sharma]
Calavo Growers, Inc. (NASDAQ:CVGW), which I’ve dubbed a “tiny, mighty dividend stock,” reported fiscal second-quarter 2018 earnings on June 6. How has this dynamic avocado market specialist fared so far in its fiscal year? Let’s dive into the quarter’s detailsafter first walking through headline numbers directly below.
- [By Ethan Ryder]
Prudential Financial Inc. raised its holdings in shares of Calavo Growers (NASDAQ:CVGW) by 5.9% during the first quarter, HoldingsChannel.com reports. The firm owned 28,216 shares of the company’s stock after acquiring an additional 1,580 shares during the quarter. Prudential Financial Inc.’s holdings in Calavo Growers were worth $2,602,000 at the end of the most recent quarter.
Top 5 Heal Care Stocks To Watch For 2019: United States Cellular Corporation(USM)
- [By Stephan Byrd]
U.S. Cellular (NYSE: USM) and Hutchison Telecommunications Hong Kong (OTCMKTS:HTHKY) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.
- [By Logan Wallace]
These are some of the media stories that may have impacted Accern Sentiment Analysis’s analysis:
Get U.S. Cellular alerts:
$962.41 Million in Sales Expected for U.S. Cellular (USM) This Quarter (americanbankingnews.com) $0.21 Earnings Per Share Expected for U.S. Cellular (USM) This Quarter (americanbankingnews.com) OneNeck IT Solutions named to CRNs 2018 Solution Provider 500 list (prweb.com) U.S. Cellular Unveils Offers on iPhones With New Connections (zacks.com)
USM has been the subject of several research analyst reports. Raymond James raised shares of U.S. Cellular from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 2nd. ValuEngine raised shares of U.S. Cellular from a “sell” rating to a “hold” rating in a research report on Monday, April 2nd. Finally, Zacks Investment Research raised shares of U.S. Cellular from a “hold” rating to a “buy” rating and set a $41.00 price objective for the company in a research report on Tuesday, February 27th.
- [By Ethan Ryder]
NII (NASDAQ: NIHD) and U.S. Cellular (NYSE:USM) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends.
Top 5 Heal Care Stocks To Watch For 2019: Orocobre Limited (OROCF)
- [By ]
In April 2018, Nemaska (OTCQX:NMKEF) drew nearly $100 million in investment from Japan’s SoftBank (OTCPK:SFTBY) group in exchange for a 9.9% interest in the company and access to lithium hydroxide produced by the company. In March 2018, CATL the world’s soon-to-be largest lithium battery manufacturer purchased a controlling stake in the Quebec Lithium project in consideration for $66 million. In February 2018, Korean steel giant, POSCO (PKX) announced a supply agreement and investment into Australian lithium miner Pilbara Minerals (OTCPK:PILBF). In January 2018, Toyota Tsusho (OTCPK:TYHOF), the strategic trading arm of Toyota Motors, invested approximately A$300 million in Orocobre (OTCPK:OROCF) in consideration for 15% of the company. Now, in April 2018, Swedish battery start-up NorthVolt has announced that it has signed an agreement for the supply of up to 5,000 metric tons per year of lithium hydroxide produced at Nemaska Lithium’s commercial plant in Shawinigan, Quebec. In connection with the supply of lithium chemicals, NorthVolt has agreed to deliver to Nemaska a 10 million euro promissory note that can be converted into voting shares of NorthVolt.
- [By ]
Early-stage lithium producer Orocobre (OTCPK:OROCF) has been busy developing its Argentine flag-ship asset at Olaroz. The company has managed to scale up the asset to around 12,000 T / year LCE with a nameplate production capacity of 17,500 T / year. Although the company has not achieved full production capacity at its asset, it has moved ahead with joint venture partner Toyota Tsusho (OTCPK:TYHOF) to develop plans for Phase 2. In January 2018, Orocobre announced that Toyota Tsusho would invest nearly $300 million for a 15% stake in the company, along with plans to double production capacity at Olaroz to 42,000 T LCE / year. The joint venture is also building a lithium hydroxide facility in Japan which will supply the local battery supply chain.